Zinc in pharmacological doses suppresses allogeneic reaction without affecting the antigenic response

Bone Marrow Transplantation

Volumn 33, Issue 12, 2004, Pages 1241-1246

  Faber, C ^a   Gabriel, P ^a   Ibs, K H ^b   Rink, L ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Alloreactivity; Zinc

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TETANUS TOXOID; TRACE ELEMENT; ZINC SULFATE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOIMMUNITY; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ANTIGEN RETRIEVAL; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; MIXED LYMPHOCYTE CULTURE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IMMUNITY; IMMUNOSUPPRESSION; INTERFERON TYPE II; LYMPHOCYTE CULTURE TEST, MIXED; MALE; TETANUS TOXIN; ZINC;

EID: 3242655603     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704509     Document Type: Article

References (33)

1. Danzer SG, Rink L. Cytokines in mixed lymphocyte culture as a prospective parameter for transplantation. Med Klin 1996; 91: 494-500.
2. Hayry P, Andersson LC, Nordling S et al. Allograft response in vitro. Transplant Rev 1972; 12: 91-140.
3. Klein J, Chiang CL. Ability of H-2 regions to induce graft-vs-host disease. J Immunol 1976; 117: 736-740.
4. Danzer SG, aCampo A, Kunze B et al. Identification of HLA-DRB1 and HLA-DQB1 identical individuals by a cytokine-based mixed lymphocyte culture. Lymphokine Cytokine Res 1994; 13: 303-308.
5. Acha OH, Held W, Scarpellino L et al. Mls: a link between immunology and retrovirology. Int Rev Immunol 1992; 8: 327-336.
6. Dickinson AM, Sviland L, Hamilton PJ et al. Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 65-70.
7. Danzer SG, aCampo C, Rink L. Interferon-gamma plays a key role in the human mixed lymphocyte culture. Bone Marrow Transplant 1996; 18: 991-996.
8. Mihatsch MJ, Kyo M, Morozumi K et al. The side-effects of cyclosporine-A and tacrolimus. Clin Nephrol 1998; 49: 356-363.
9. Wellinghausen N, Kirchner H, Rink L. The immunobiology of zinc. Immunol Today 1997; 18: 519-520.
10. Wellinghausen N, Rink L. The significance of zinc for leukocyte biology. J Leukoc Biol 1998; 64: 571-577.
11. Rink L, Gabriel P. Zinc and the immune system. Proc Nutr Soc 2000; 59: 541-552.
12. Allen JL, Perri RT, McClain CJ et al. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency. J Lab Clin Med 1983; 102: 577-589.
13. Keen CL, Gershwin ME. Zinc deficiency and immune function. Ann Rev Nutr 1990; 10: 415-431.
14. Fraker PJ, King LE, Laakko T et al. The dynamic link between the integrity of the immune system and zinc status. J Nutr 2000; 130 (Suppl. 5S): 1399S-1406S.
15. Prasad AS. Zinc and immunity. Mol Chem Biochem 1998; 188: 63-69.
16. Depasquale-Jardieu P, Fraker PJ. Interference in the development of a secondary immune response in mice by zinc deprivation: persistence of effects. J Nutr 1984; 114: 1762-1769.
17. Minigari MC, Morretta A, Moretta L. Regulation of KIR expression in human T cells: a safety mechanism that repairs protective T cell responses. Immunol Today 1998; 19: 153-157.
18. Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in the elderly. Lancet 1992; 340: 1124-1137.
19. Wellinghausen N, Martin M, Rink L. Zinc inhibits interleukin-1-dependent T cell stimulation. Eur J Immunol 1997; 27: 2529-2535.
20. aCampo C, Wellinghausen N, Faber C et al. Zinc inhibits the mixed lymphocyte culture. Biol Trace Elem Res 2001; 79: 15-22.
21. Driessen C, Hirv K, Rink L et al. Induction of cytokines by zinc ions in human peripheral blood mononuclear cells and separated monocytes. Lymphokine Cytokine Res 1994; 13: 15-20.
22. Prasad AS, Fitzgerald JT, Bao B et al. Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 133: 245-252.
23. Danzer SG, Kirchner H, Rink L. Cytokine interactions in human mixed lymphocyte culture. Transplantation 1994; 57: 1638-1642.
24. Bonham M, O'Connor JM, Alexander HD et al. Zinc supplementation has no effect on circulating levels of peripheral blood leucocytes and lymphocyte subsets in healthy adult men. Br J Nutr 2003; 89: 695-703.
25. Woo J, Sewell HF, Thomson AW. The influence of FK-506 and low-concentration cyclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis. Scand. J Immunol 1990; 31: 297-304.
26. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338: 1741-1751.
27. *0201 is expressed at low abundance and recognized by an alloreactive CD8 + cytotoxic T cell with apparent high affinity. J Immunol 1997; 158: 5707-5804.
28. Bevan MJ. High determinant density may explain the phenomenon of alloreactivity. Immunol Today 1984; 5: 128-130.
29. Obst R, Netuschil N, Klopfer K et al. The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules. J Exp Med 2000; 191: 805-812.
30. Fraser JD, Urban RG, Strominger JL et al. Zinc regulates the function of two superantigens. Proc Natl Acad Sci USA 1992; 89: 5507-5511.
31. Liu KD, Gaffen SL, Goldsmith MA. JAK/STAT signaling by cytokine receptors. Curr Opin Immunol 1998; 10: 271-278.
32. Welte T, Leitenberg L, Dittel BN et al. STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science 1999; 283: 222-225.
33. Gerwien J, Nielsen M, Labuda T et al. Cutting edge: TCR stimulation by antibody and bacterial superantigen induces STAT3 activation in human T cells. J Immunol 1999; 163: 1742-1745.